AEMD (Aethlon Medical) FCF Yield %: -415.81 (As of Jul. 03, 2026)


AEMD Aethlon Medical Inc AEMD
23 GF Score
Price $0.74
! 1 Warning Sign
View Full Analysis

What is Aethlon Medical FCF Yield %?

Aethlon Medical AEMD -6.07% 23 FCF Yield % is -415.81 as of Jul. 03, 2026. GuruFocus rates AEMD with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 857 Medical Devices & Instruments companies, Aethlon Medical ranks worse than 98.6% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Aethlon Medical's Trailing 12-Month Free Cash Flow is $-7.00 Mil, and Market Cap is $1.68 Mil. Therefore, Aethlon Medical's FCF Yield % for today is -415.81%.

The historical rank and industry rank for Aethlon Medical's FCF Yield % or its related term are showing as below:

AEMD' s FCF Yield % Range Over the Past 10 Years
Min: -46984.29   Med: -497.52   Max: -49.11
Current: -415.81


During the past 13 years, the highest FCF Yield % of Aethlon Medical was -49.11%. The lowest was -46984.29%. And the median was -497.52%.

AEMD's FCF Yield % is ranked worse than
98.6% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: -0.4 vs AEMD: -415.81

Aethlon Medical's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Aethlon Medical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Aethlon Medical FCF Yield % Related Terms


Aethlon Medical FCF Yield % Historical Data

* Premium members only.

The historical data trend for Aethlon Medical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aethlon Medical FCF Yield % Chart

Aethlon Medical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -455.84 -1,290.06 -2,340.59 -132.82 -203.65

Aethlon Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -116.25 -219.87 -116.47 -278.12 -203.59

AEMD vs VYCO, RBOT, ESMC: FCF Yield % Comparison

For the Medical Devices subindustry, Aethlon Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aethlon Medical FCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aethlon Medical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Aethlon Medical's FCF Yield % falls into.


AEMD
23GF Score
Aethlon Medical Inc AEMD
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aethlon Medical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Aethlon Medical's FCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-7.002 / 3.4383
=-203.65%

Aethlon Medical's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.75 * 4 / 3.4383
=-203.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -415.81 mean?
Aethlon Medical (AEMD) has a FCF Yield % of -415.81 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Aethlon Medical and its competitors. According to the industry distribution chart, Aethlon Medical ranks #845 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 98.6%.
Is Aethlon Medical's FCF Yield % too high?
Aethlon Medical's current FCF Yield % is -415.81. Based on the distribution chart, Aethlon Medical ranks #845 out of 857 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Aethlon Medical has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Aethlon Medical's FCF Yield % compare to VYCO and RBOT?
According to the Medical Devices & Instruments industry distribution chart, Aethlon Medical ranks #845 out of 857 companies for FCF Yield %. This places Aethlon Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Aethlon Medical and its competitors. Aethlon Medical's current FCF Yield % is -415.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aethlon Medical stock overvalued right now?
Aethlon Medical (AEMD) has a current FCF Yield % of -415.81. The current FCF Yield % is -415.81. Aethlon Medical's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Aethlon Medical (AEMD), the current FCF Yield % is -415.81 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aethlon Medical Business Description

Address 11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
23GF Score

Get the complete analysis for AEMD

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.74
Price